The increase in price target by Goldman Sachs suggests a positive outlook on Teradyne's future performance, potentially leading to increased investor confidence and a short-term positive impact on TER's stock price. The Neutral rating indicates that the stock is adequately valued at its current price, but the raised target suggests room for growth.